Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Apr;61(4):286-303.
doi: 10.1007/s12033-019-00156-8.

Phage Display Libraries: From Binders to Targeted Drug Delivery and Human Therapeutics

Affiliations
Review

Phage Display Libraries: From Binders to Targeted Drug Delivery and Human Therapeutics

Mouldy Sioud. Mol Biotechnol. 2019 Apr.

Abstract

The application of repertoire selection technologies for the study and characterization of tumor heterogeneity is an area of great interest in the field of tumor biology and immunotherapy. Among the most promising approaches, phage display has been successfully used to select peptides and antibody fragments to a variety of different targets, including cancer cells, immune cells and cytokines. Peptides selected from phage display have been used to guide the delivery of lytic peptides, cytotoxic drugs, and nanoparticles to cancer cells with the aim to obtain more efficient and less toxic therapeutics. Additionally, antibodies developed through phage display are being used in the treatment of autoimmune diseases and in some cases metastatic cancers. This review provides a short description of how phage libraries are designed, and highlights the conversion of the isolated binders into human therapeutics and use in targeted therapies.

Keywords: Affinity selection; Antibodies; Biomarkers; Drug delivery; Immunotherapy; Peptides; Phage display; Targeted therapies.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Biol Chem. 1999 Jun 25;274(26):18218-30 - PubMed
    1. Nat Biotechnol. 1999 Aug;17(8):768-74 - PubMed
    1. J Mol Biol. 1999 Nov 5;293(4):865-81 - PubMed
    1. J Immunol Methods. 1999 Dec 10;231(1-2):11-23 - PubMed
    1. J Mol Biol. 2000 Feb 11;296(1):57-86 - PubMed

Grants and funding

LinkOut - more resources